Protective Effect of Natural Products against Huntington's Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action
- PMID: 33475334
- DOI: 10.1021/acschemneuro.0c00824
Protective Effect of Natural Products against Huntington's Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action
Abstract
Huntington's disease (HD), a neurodegenerative disease, normally starts in the prime of adult life, followed by a gradual occurrence of characteristic psychiatric disturbances and cognitive and motor dysfunction. To the best of our knowledge, there is no treatment available to completely mitigate the progression of HD. Among various therapeutic approaches, exhaustive literature reports have confirmed the medicinal benefits of natural products in HD experimental models. Building on this information, this review presents a brief overview of the neuroprotective mechanism(s) of natural products against in vitro/in vivo models of HD. Relevant studies were identified from several scientific databases, including PubMed, ScienceDirect, Scopus, and Google Scholar. After screening through literature from 2005 to the present, a total of 14 medicinal plant species and 30 naturally isolated compounds investigated against HD based on either in vitro or in vivo models were included in the present review. Behavioral outcomes in the HD in vivo model showed that natural compounds significantly attenuated 3-nitropropionic acid (3-NP) induced memory loss and motor incoordination. The biochemical alteration has been markedly alleviated with reduced lipid peroxidation, increased endogenous enzymatic antioxidants, reduced acetylcholinesterase activity, and increased mitochondrial energy production. Interestingly, following treatment with certain natural products, 3-NP-induced damage in the striatum was ameliorated, as seen histologically. Overall, natural products afforded varying degrees of neuroprotection in preclinical studies of HD via antioxidant and anti-inflammatory properties, preservation of mitochondrial function, inhibition of apoptosis, and induction of autophagy.
Keywords: 3-nitropropionic acid; Huntington’s disease; herbal medicine; natural products; neurodegenerative; neuroprotective.
Similar articles
-
A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease.Mol Neurobiol. 2024 Mar;61(3):1237-1270. doi: 10.1007/s12035-023-03604-4. Epub 2023 Sep 12. Mol Neurobiol. 2024. PMID: 37698833 Review.
-
Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.Biomed Pharmacother. 2018 Sep;105:1254-1268. doi: 10.1016/j.biopha.2018.06.079. Epub 2018 Jun 22. Biomed Pharmacother. 2018. PMID: 30021362
-
Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.J Med Food. 2009 Jun;12(3):591-600. doi: 10.1089/jmf.2008.0028. J Med Food. 2009. PMID: 19627208
-
Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms in Rats.J Huntingtons Dis. 2024;13(1):55-66. doi: 10.3233/JHD-231507. J Huntingtons Dis. 2024. PMID: 38489193
-
3-Nitropropionic acid animal model and Huntington's disease.Neurosci Biobehav Rev. 1997 May;21(3):289-93. doi: 10.1016/s0149-7634(96)00027-9. Neurosci Biobehav Rev. 1997. PMID: 9168265 Review.
Cited by
-
Anti-Huntington's Effect of Rosiridin via Oxidative Stress/AchE Inhibition and Modulation of Succinate Dehydrogenase, Nitrite, and BDNF Levels against 3-Nitropropionic Acid in Rodents.Biomolecules. 2022 Jul 23;12(8):1023. doi: 10.3390/biom12081023. Biomolecules. 2022. PMID: 35892333 Free PMC article.
-
Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disorders: An Overview of Scientific Evidence and Understanding Their Mechanism of Action.Drug Des Devel Ther. 2022 Jan 6;16:23-66. doi: 10.2147/DDDT.S326332. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35027818 Free PMC article. Review.
-
Repurposing Oseltamivir Against CAG Repeat Mediated Toxicity in Huntington's Disease and Spinocerebellar Ataxia Using Cellular and Drosophila Model.ACS Omega. 2025 Feb 22;10(15):14980-14993. doi: 10.1021/acsomega.4c10338. eCollection 2025 Apr 22. ACS Omega. 2025. PMID: 40290909 Free PMC article.
-
Targeting Protein Aggregates with Natural Products: An Optional Strategy for Neurodegenerative Diseases.Int J Mol Sci. 2023 Jul 10;24(14):11275. doi: 10.3390/ijms241411275. Int J Mol Sci. 2023. PMID: 37511037 Free PMC article.
-
A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease.Mol Neurobiol. 2024 Mar;61(3):1237-1270. doi: 10.1007/s12035-023-03604-4. Epub 2023 Sep 12. Mol Neurobiol. 2024. PMID: 37698833 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous